KILL Mydecine Innovations Group Upsizes Previously Announced Bought Deal

Rhea-AI Summary

Mydecine Innovations Group has requested the retraction of a press release titled “Mydecine Innovations Group Upsizes Previously Announced Bought Deal,” issued by Miller Thomson LLP.

This request is made due to the lack of prior authorization from Mydecine, indicating potential issues in communications and press management.

Positive

• None.

Negative

• Lack of prior authorization may indicate communication issues within the company.
• Retracting a press release could lead to confusion among investors and stakeholders.

Miller Thomson LLP requests that their press release NewsItemId: 20210120005543 “Mydecine Innovations Group Upsizes Previously Announced Bought Deal” be killed.

The release was issued by Miller Thomson LLP without prior authorization from Mydecine Innovations Group.

FAQ

What was the press release about Mydecine Innovations Group?

The press release requested the retraction of a previously announced bought deal, which lacked authorization from Mydecine.

Who issued the press release that Mydecine wants to retract?

The press release was issued by Miller Thomson LLP.

What is the significance of the retraction request by Mydecine Innovations Group?

The request highlights potential communication issues and the need for proper authorization in press releases.